146 related articles for article (PubMed ID: 37280145)
1. Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
Massi D; Szumera-Ciećkiewicz A; Alos L; Simi S; Ugolini F; Palmieri G; Stanganelli I; Cook MG; Mandalà M
Eur J Cancer; 2023 Aug; 189():112921. PubMed ID: 37280145
[TBL] [Abstract][Full Text] [Related]
2. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
[TBL] [Abstract][Full Text] [Related]
3. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.
van Dijk MC; Aben KK; van Hees F; Klaasen A; Blokx WA; Kiemeney LA; Ruiter DJ
Histopathology; 2008 Jan; 52(2):139-46. PubMed ID: 18184263
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
[TBL] [Abstract][Full Text] [Related]
5. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
6. Integrated diagnosis of nevi with severely atypical features and impact of second opinions.
Uzundere C; Akay BN; Heper AO; Clark SP; Tschandl P; Kittler H
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1184-1189. PubMed ID: 36840392
[TBL] [Abstract][Full Text] [Related]
7. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
8. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management.
Ronen S; Al-Rohil RN; Keiser E; Jour G; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Middleton LP; Torres-Cabala CA; Gershenwald JE; Aung PP; Prieto VG
Arch Pathol Lab Med; 2021 Dec; 145(12):1505-1515. PubMed ID: 33577643
[TBL] [Abstract][Full Text] [Related]
9. Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.
Geller BM; Frederick PD; Knezevich SR; Lott JP; Nelson HD; Titus LJ; Carney PA; Tosteson ANA; Onega TL; Barnhill RL; Weinstock MA; Elder DE; Piepkorn MW; Elmore JG
Dermatol Surg; 2018 Feb; 44(2):177-185. PubMed ID: 28858936
[TBL] [Abstract][Full Text] [Related]
10. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
[TBL] [Abstract][Full Text] [Related]
11. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
Tosteson ANA; Tapp S; Titus LJ; Nelson HD; Longton GM; Bronson M; Pepe M; Carney PA; Onega T; Piepkorn MW; Knezevich SR; Barnhill R; Weinstock MA; Elder DE; Elmore JG
JAMA Dermatol; 2021 Sep; 157(9):1102-1106. PubMed ID: 34076664
[TBL] [Abstract][Full Text] [Related]
12. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
13. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and melanoma in-situ diagnosis after excision of atypical intraepidermal melanocytic proliferation: A retrospective cross-sectional analysis.
Blank NR; Hibler BP; Tattersall IW; Ensslin CJ; Lee EH; Dusza SW; Nehal KS; Busam KJ; Rossi AM
J Am Acad Dermatol; 2019 May; 80(5):1403-1409. PubMed ID: 30654079
[TBL] [Abstract][Full Text] [Related]
15. Atypical melanocytic lesions: a historical overview.
Manchi M; Canzonieri V
Pol J Pathol; 2019; 70(1):26-32. PubMed ID: 31556548
[TBL] [Abstract][Full Text] [Related]
16. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
17. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
Shoo BA; Sagebiel RW; Kashani-Sabet M
J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
[TBL] [Abstract][Full Text] [Related]
18. Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
Jafry MA; Peacock S; Radick AC; Shucard HL; Reisch LM; Piepkorn MW; Knezevich SR; Weinstock MA; Barnhill RL; Elder DE; Kerr KF; Elmore JG
J Am Acad Dermatol; 2020 Jun; 82(6):1435-1444. PubMed ID: 31862403
[TBL] [Abstract][Full Text] [Related]
19. Histologic Screening of Malignant Melanoma, Spitz, Dermal and Junctional Melanocytic Nevi Using a Deep Learning Model.
Snyder AN; Zhang D; Dreesen SL; Baltimore CA; Lopez-Garcia DR; Akers JY; Metts CL; Madory JE; Chang PD; Doan LT; Elston DM; Valdebran MA; Luo F; Forcucci JA
Am J Dermatopathol; 2022 Sep; 44(9):650-657. PubMed ID: 35925282
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma.
Katz I; O'Brien B; Clark S; Thompson CT; Schapiro B; Azzi A; Lilleyman A; Boyle T; Espartero LJL; Yamada M; Prow TW
JAMA Netw Open; 2021 Dec; 4(12):e2134614. PubMed ID: 34889949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
